Home
Immutep Ltd
Update on Phase I Study of IMP761 for Autoimmune Diseases
Business
Mar 19 2026
4 min read

Update on Phase I Study of IMP761 for Autoimmune Diseases

news images

Immutep Ltd has released a press release.

View Attachment